Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use
Feasibility of an Art-based Intervention to Address Clinician Stigma and Improve Care for Neonatal Opioid Withdrawal Syndrome
2 other identifiers
interventional
99
1 country
2
Brief Summary
The goal of this pilot clinical trial is to evaluate the feasibility and limited effectiveness of a digital, arts-based educational intervention addressing nurse stigma towards perinatal substance use. The main questions it aims to answer are:
- What is the the feasibility of delivering the training through an asynchronous, web-based platform?
- What is the limited effectiveness of the program on nurse stigma towards perinatal substance use? Participants will access and complete the training, including completion of a perinatal substance use stigma scale at baseline, immediately post, and 1-2 months month later. Participants will also be invited to participate in an interview. Researchers will compare the intervention and control groups to see if the training reduces nurse stigma towards perinatal substance use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedResults Posted
Study results publicly available
March 11, 2026
CompletedMarch 11, 2026
March 1, 2026
5 months
May 7, 2024
October 15, 2025
March 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Nurse Stigma Toward Perinatal Substance Use
Negative or stigmatizing attitudes and/or beliefs registered nurses have towards perinatal substance use; measured using the Modified Attitudes About Drug Use in Pregnancy Scale. Total scores range between 1 and 5, with scores closer to 1 associated with a more positive outcome.
Baseline (Phase 1a); immediately post intervention (Site 1) or 7-30 days post baseline (Site 2) (Phase 1b); immediately post (Site 2) or 30 days post intervention (Site 1) (Phase 2); 30 days post (Site 2) or 60 days post intervention (Site 1) (Phase 3)
Secondary Outcomes (1)
Acceptability
immediately post intervention (Site 1= Phase 1b; Site 2 = Phase 2)
Study Arms (2)
Site 1
EXPERIMENTALParticipants from the hospital randomized to the experimental group will be first to receive an invitation to complete the web-based educational program. The program will be open for one month. Thirty days after a participant completes the program, they will be sent a link to a follow up survey (web-based). At 60 days, participants who completed the program and the first follow up survey will be randomized to complete a second follow up survey or participate in a 1:1 interview.
Site 2
OTHERParticipants from the hospital randomized to the control setting will receive an invitation to complete a survey that collects baseline data for the outcome (stigma toward perinatal substance use) and demographic information. After thirty days, participants will be invited to complete the web-based educational program. Thirty days after completion, they will receive a link to a web-based follow up survey.
Interventions
ArtSpective is an interactive, educational program that uses art and museum-based pedagogy. The intervention is delivered asynchronously using a web-based platform. Participants engage with artwork, watch short educational videos, and read short clinical vignettes. After completing the program, participants receive a certificate of completion.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Licensed as a registered nurse
- Works at least part time
- Works on a labor, postpartum, nursery, neonatal intensive care, or pediatric unit in one of the participating hospitals
You may not qualify if:
- Works as per diem or agency nurse
- Not employed by a participating hospital
- Not a perinatal/pediatric nurse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
St. Cloud Hospital
Saint Cloud, Minnesota, 56303, United States
ProMedica Toledo Hospital
Toledo, Ohio, 43606, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clayton Shuman, PhD, MSN, RN; Associate Professor
- Organization
- University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 7, 2024
First Posted
May 13, 2024
Study Start
July 1, 2024
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
March 11, 2026
Results First Posted
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
De-identified data may be shared upon request.